Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Prognostic impact of WT1 mutations in patients with acute myeloid leukemia].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026
Same author

Psychometric properties of the Chinese version of 21-item Fall Risk Index for community-dwelling older adults with stroke.

European journal of physical and rehabilitation medicine·2025
Same author

3D Capsule Networks for Brain Image Segmentation.

AJNR. American journal of neuroradiology·2023
Same author

Multisystem Langerhans cell histiocytosis with diabetes insipidus in an adult.

Indian journal of dermatology·2022
Same author

[Value of heart rate-blood pressure product of multiplication for identifying compensated shock in children].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2021
Same author

[Application of mixed reality technique for the surgery of oral and maxillofacial tumors].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2020

Related Experiment Video

Updated: Jul 5, 2026

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

[Antitumor effect on melanoma by in vivo direct injection of packaging cells transfected recombinant IL-2 gene].

Y Zhu1, Y Wu, Y Hui

  • 1Cancer Institute, CAMS, Beijing.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae
|April 1, 1997
PubMed
Summary

Directly injecting mice with IL-2 gene therapy reduced melanoma tumor size and extended survival. This gene transfer approach shows promise for effective cancer treatment by enhancing anti-tumor immunity.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Related Experiment Videos

Last Updated: Jul 5, 2026

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Area of Science:

  • Oncology
  • Gene Therapy
  • Immunology

Context:

  • Previous research demonstrated ex vivo IL-2 gene transfer into B16 melanoma cells inhibited tumor growth.
  • Melanoma is a significant form of skin cancer with a need for improved therapeutic strategies.

Purpose:

  • To evaluate the efficacy of in vivo direct gene transfer of the IL-2 gene into B16 melanoma tumors.
  • To assess the impact of IL-2 gene therapy on tumor size, survival rates, and immune response in a murine model.

Summary:

  • Mice with B16 melanoma were directly injected with PA317 cells producing recombinant IL-2.
  • In vivo gene transfer resulted in significant tumor size reduction and prolonged survival.
  • IL-2 mRNA expression was detected in tumors, and enhanced IFN-gamma activity was observed.

Impact:

  • Direct in vivo IL-2 gene transfer effectively inhibits melanoma tumor growth.
  • This approach induces anti-tumor effects by transferring genes into tumor cells and boosting immune response.
  • The study supports the potential of retroviral vector-mediated IL-2 gene therapy for cancer treatment.